144 related articles for article (PubMed ID: 10931892)
1. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host.
Odds FC; Van Nuffel L; Gow NAR
Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1881-1889. PubMed ID: 10931892
[TBL] [Abstract][Full Text] [Related]
2. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
Matuschak GM; Lechner AJ
Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
[TBL] [Abstract][Full Text] [Related]
3. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.
Fakhim H; Vaezi A; Dannaoui E; Chowdhary A; Nasiry D; Faeli L; Meis JF; Badali H
Mycoses; 2018 Jun; 61(6):377-382. PubMed ID: 29460345
[TBL] [Abstract][Full Text] [Related]
4. SR-like RNA-binding protein Slr1 affects Candida albicans filamentation and virulence.
Ariyachet C; Solis NV; Liu Y; Prasadarao NV; Filler SG; McBride AE
Infect Immun; 2013 Apr; 81(4):1267-76. PubMed ID: 23381995
[TBL] [Abstract][Full Text] [Related]
5. Reduced virulence of Candida albicans mutants lacking the GNA1 gene encoding glucosamine-6-phosphate acetyltransferase.
Mio T; Kokado M; Arisawa M; Yamada-Okabe H
Microbiology (Reading); 2000 Jul; 146 ( Pt 7)():1753-1758. PubMed ID: 10878139
[TBL] [Abstract][Full Text] [Related]
6. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
MacCallum DM; Odds FC
Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
[TBL] [Abstract][Full Text] [Related]
8. [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].
Aydın C; Ataoğlu H
Mikrobiyol Bul; 2015 Jan; 49(1):66-76. PubMed ID: 25706732
[TBL] [Abstract][Full Text] [Related]
9. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
[TBL] [Abstract][Full Text] [Related]
10. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
11. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
[TBL] [Abstract][Full Text] [Related]
12. Examination of the pathogenic potential of Candida albicans filamentous cells in an animal model of haematogenously disseminated candidiasis.
Cleary IA; Reinhard SM; Lazzell AL; Monteagudo C; Thomas DP; Lopez-Ribot JL; Saville SP
FEMS Yeast Res; 2016 Mar; 16(2):fow011. PubMed ID: 26851404
[TBL] [Abstract][Full Text] [Related]
13. Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis.
Spellberg B; Johnston D; Phan QT; Edwards JE; French SW; Ibrahim AS; Filler SG
Infect Immun; 2003 Oct; 71(10):5756-64. PubMed ID: 14500497
[TBL] [Abstract][Full Text] [Related]
14. Mannan estimation as a measure of the growth of Candida albicans.
Pike IH; Evans EG; Carney JA
J Med Vet Mycol; 1991; 29(2):83-91. PubMed ID: 1880683
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans.
Vilela MM; Kamei K; Sano A; Tanaka R; Uno J; Takahashi I; Ito J; Yarita K; Miyaji M
Med Mycol; 2002 Jun; 40(3):249-57. PubMed ID: 12146754
[TBL] [Abstract][Full Text] [Related]
16. Virulence and karyotype analyses of rad52 mutants of Candida albicans: regeneration of a truncated chromosome of a reintegrant strain (rad52/RAD52) in the host.
Chauhan N; Ciudad T; Rodríguez-Alejandre A; Larriba G; Calderone R; Andaluz E
Infect Immun; 2005 Dec; 73(12):8069-78. PubMed ID: 16299301
[TBL] [Abstract][Full Text] [Related]
17. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load.
Ashman RB; Fulurija A; Papadimitriou JM
Infect Immun; 1996 May; 64(5):1866-9. PubMed ID: 8613406
[TBL] [Abstract][Full Text] [Related]
18. Adherence in tissues of immunocompromised mice of a non-mycelium producing strain of Candida albicans.
Vespa MN
Mycoses; 2000; 43(5):185-9. PubMed ID: 10948817
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pathogenicity of various Candida albicans and C. stellatoidea strains.
Okawa Y; Miyauchi M; Takahashi S; Kobayashi H
Biol Pharm Bull; 2007 Oct; 30(10):1870-3. PubMed ID: 17917253
[TBL] [Abstract][Full Text] [Related]
20. Parameters for determination of Candida albicans virulence in murine peritonitis.
Kretschmar M; Bertsch T; Göller M; Schaller M; Hof H; Nichterlein T
Mycoses; 1999; 42 Suppl 2():19-24. PubMed ID: 10865898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]